CORRECTION article

Front. Immunol., 01 October 2018

Sec. Primary Immunodeficiencies

Volume 9 - 2018 | https://doi.org/10.3389/fimmu.2018.02197

Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?

  • 1. Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Center of Child and Adolescent Health, Heinrich-Heine-University, Düsseldorf, Germany

  • 2. Institute for Virology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany

  • 3. Research Unit Lung Repair and Regeneration, Comprehensive Pneumology Center, Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Munich, Germany

  • 4. University Hospital Grosshadern, Ludwig-Maximilians-Universität München, Munich, Germany

  • 5. German Center for Lung Research (DZL), Giessen, Germany

  • 6. Paediatric Immunology and HSCT, Newcastle University and Great North Children's Hospital, Newcastle upon Tyne, United Kingdom

Article metrics

View details

3

Citations

1,4k

Views

567

Downloads

A mistake was made in the authorship. Heiko Adler, who contributed to the unpublished murine experiments, which are indicated in the last chapter, was unintentionally omitted from the author's list. Therefore, he should be included in the authorship. The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way.

The original article has been updated.

Statements

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Summary

Keywords

Epstein–Barr virus-related malignancies, combined immunodeficiency, Interleukin-2-inducible T-cell kinase, lymphoproliferative disorders, primary immunodeficiency

Citation

Ghosh S, Drexler I, Bhatia S, Adler H, Gennery AR and Borkhardt A (2018) Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?. Front. Immunol. 9:2197. doi: 10.3389/fimmu.2018.02197

Received

14 August 2018

Accepted

05 September 2018

Published

01 October 2018

Approved by

Frontiers in Immunology Editorial Office, Frontiers Media SA, Switzerland

Volume

9 - 2018

Updates

Copyright

*Correspondence: Sujal Ghosh

This article was submitted to Primary Immunodeficiencies, a section of the journal Frontiers in Immunology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics